Abbreviated Company Accounts - PLAYSCHEME LIMITED

PLAYSCHEME LIMITED - Company Information

Registered Number 02258358

PLAYSCHEME LIMITED

Abbreviated Accounts

31 December 2015

PLAYSCHEME LIMITED Registered Number 02258358

Abbreviated Balance Sheet as at 31 December 2015

	2015	2014
	£	£
Called up share capital not paid	100	100
Total assets less current liabilities	100	100
Total net assets (liabilities)	100	100
Capital and reserves
Called up share capital	100	100
Shareholders' funds	100	100

For the year ending 31 December 2015 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 9 August 2016

And signed on their behalf by:
J Murphy, Director

PLAYSCHEME LIMITED Registered Number 02258358

Notes to the Abbreviated Accounts for the period ended 31 December 2015

1Accounting Policies

Basis of measurement and preparation of accounts
The accounts have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities effective April 2008.

Turnover policy
During the financial year and the preceding financial year the company did not trade and received no income and incurred no expenditure. Consequently during these periods the company made neither a profit nor a loss.

Other accounting policies
Transactions with directors:
No remuneration was paid to the directors during the year or in the previous year.

Related party transactions:
The company has taken advantage of the exemption not to disclose related party transactions with members of the Skyepharma group or associates and joint ventures of other group companies.

Cashflow statement:
The company is a wholly owned subsidiary of an EC company which publishes consolidated accounts that include a consolidated cashflow statement and therefore is not required to produce a cashflow statement.

Contingent liabilities:
There were no contingent liabilities as at 31 December 2015 and 31 December 2014.

Ultimate parent undertaking:
Skyepharma PLC is registered in England and Wales and is considered by the directors to be the ultimate parent undertaking. Copies of the group accounts are available from 46-48 Grosvenor Gardens, London SW1W 0EB.

Called Up Share Capital:
Allotted and called up: 100 Ordinary Shares of £1 each in both 2015 and 2014